Robert J. Terifay, SVP Commercial at REGENERON PHARMACEUTICALS INC (REGN), sold 24,375 shares at $423.67 ($10.4M) on 2015-02-24, disclosed to the SEC on 2015-02-25.
Scheduled sale ($10.4M) by SVP Commercial under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $427.94 | 1,744 | $746K | 7.2% |
| 2 | $427.94 | 11,458 | $4.9M | 47.2% |
| 3 | $423.67 | 11,173 | $4.7M | 45.6% |
| Total | $425.98 avg | 24,375 | $10.4M | 100% |
| Filing → |
| REGN | SELL | 2015-03-18 | $5.0M | — | Filing → |
| REGN | SELL | 2014-11-19 | $9.1M | — | Filing → |
| REGN | SELL | 2014-02-19 | $4.3M | — | Filing → |